Respiratory viral infections cause significant global disease burden with influenza, or flu, being responsible for a significant portion. An estimated 1 billion cases of influenza occur annually resulting in approximately 3–5 million severe cases and 290,000–650,000 deaths (WHO, 2018). In addition to seasonal epidemics caused by both influenza A or B virus (IAV and IBV, respectively), IAV can also cause pandemics. The majority of infections remain asymptomatic or develop mild to moderate respiratory disease, characterized by fever, nasal congestion, cough, and muscle aches. Severe disease mainly affects infants, pregnant women, and the elderly or immunocompromised, but can also occur in otherwise healthy individuals (Cole et al., 2017; Oshansky et al., 2014). The determinants of disease severity are still incompletely understood but may include properties of the virus, environmental factors, genetics, and immune responses of the patient (Kuiken and Taubenberger, 2008; Kuiken et al., 2010). Other agents causing an influenza-like illness (ILI) during influenza season include respiratory syncytial virus (RSV) and seasonal coronaviruses (OC43, HKU1, 229E, and NL63). Similar to IAV, coronaviruses are capable of causing pandemics, most notably the ongoing coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Zhou et al., 2020).

IAV is primarily transmitted via inhalation of virus-containing aerosols or droplets, and mainly targets respiratory epithelial cells (Tellier, 2006; Sanders et al., 2011), with the nasopharynx being the initial site of virus replication. IAV generally remains localized to the airways, despite signs of systemic inflammation (Stramer et al., 2012). At the site of infection, resident innate immune cells including monocytes and dendritic cells (DCs) rapidly respond to the presence of virus by secreting cytokines, interferons, and chemokines to limit viral spread and recruit immune cells (Sakabe et al., 2011; Wang et al., 2012). Monocytes and DCs shape the specificity and strength of the subsequent adaptive responses (Kwissa et al., 2014; Spörri and Reis e Sousa, 2005). In blood, three subsets of monocytes are found: the CD14+CD16– classical monocytes (CMs), the most frequent subset at steady state; the terminally differentiated CD14–CD16+ nonclassical monocytes (NCMs); and CD14+CD16+ intermediate monocytes (IMs) that represent CMs transitioning into NCMs (Boyette et al., 2017; Jakubzick et al., 2013; Patel et al., 2017). Blood IMs are readily identifiable at steady state and expand rapidly in response to inflammation, infection, or vaccination (Oshansky et al., 2014; Kwissa et al., 2014; Fingerle et al., 1993). In addition, monocytes extravasate to tissue where they play an important role in innate immune protection. Monocytes also secrete TNFα, a major regulator of innate immune function that is central to the cytokine storm associated with IAV infection (Tisoncik et al., 2012). Conventionally, DCs were grouped as the CD1c+ myeloid DCs (MDCs) that excel at activating naïve T cells Hémont et al., 2013; the CD141+ MDCs that can efficiently can cross-present antigens via MHC-I Jongbloed et al., 2010; and the CD123+ plasmacytoid DCs (PDCs) that mediate type I IFN responses (Cella et al., 1999). More recent single-cell sequencing and unbiased clustering revealed six subtypes of DCs and four subtypes of monocytes (Villani et al., 2017). In this manuscript, we focus on cDC1 (previously CD141+ MDCs) and cDC2 (previously CD1c+ MDCs). We also speculate the roles for DC3s (inflammatory CD14-expressing CD1c+ MDCs, which seemingly arise in a GM-CSF-dependent manner) (Bourdely et al., 2020) and pre-DCs (AXL+SIGLEC6+CD11c^lowCD123+DCs that do not produce IFNα upon TLR9 stimulation but produce IL-12p70 at levels comparable to cDCs) (Villani et al., 2017; See et al., 2017). Monocytes and DCs vary in distribution and function, depending on the anatomical compartment (Baharom et al., 2016; Alcántara-Hernández et al., 2017). Moreover, monocytes and DCs are susceptible to IAV infection in vitro, and the cytopathic nature of the virus may impair their antigen processing and presenting functions (Smed-Sörensen et al., 2012; Diao et al., 2014; Baharom et al., 2015), delaying recovery and normalization of immune cell distribution and function (Jochems et al., 2018; Lichtner et al., 2011).

Studies have shown that monocytes and DCs are recruited to the nasopharynx following infection with 2009 H1N1pdm IAV strains (Oshansky et al., 2014), and in individuals hospitalized with severe influenza infections (Gill et al., 2008; Gill et al., 2005). Disease severity in hospitalized patients has been shown to correlate with (1) monocyte recruitment and increased levels of MCP3, IFNα-2, and IL-10 in the nasal compartment (Oshansky et al., 2014) and (2) strong TNF-producing monocytic responses in blood (Cole et al., 2017) and inflammatory, neutrophil-dominant patterns (Dunning et al., 2018). Despite accounting for a comparatively greater burden of disease, immune responses during mild seasonal influenza infections remain less studied. Therefore, the roles played by monocytes and DCs in contributing to or mitigating mild influenza disease are largely unknown. Additionally, while the response of blood monocytes and DCs to IAV has been studied well in vitro and in animal models (Smed-Sörensen et al., 2012; Diao et al., 2014; Jochems et al., 2018; Vangeti et al., 2019; McGill et al., 2008; Mount and Belz, 2010; GeurtsvanKessel et al., 2008), few studies compare responses between blood and the nasopharynx in human infections (Dunning et al., 2018; Vangeti et al., 2019; Segura et al., 2013). Immune cell behaviour in the nasopharynx during IBV and RSV infections has not been studied in great detail but evidence of DC mobilization to the nasal cavity has been reported (Gill et al., 2008). Studies on immune responses to mild SARS-CoV-2 infection have also primarily focused on blood and rarely the upper airways (Mick et al., 2020).

Here, we determined monocyte and DC subset distribution, maturation and function in both blood and, for the first time, the nasopharynx, in patients with mild to moderate seasonal influenza and influenza-like infections. The methods described in this study allowed us to investigate airway immunity in a larger cohort of patients with SARS-CoV-2 infection (Falck-Jones et al., 2021; Cagigi et al., 2021), showing that methods to study the immune responses in the nasopharynx during acute disease are essential tools as we face the possibility of future pandemics. Comparing the dynamics of systemic and nasopharyngeal immune function will add to our understanding of the roles of monocytes and DCs in shaping the nature and magnitude of inflammation and subsequently disease severity during respiratory viral infections.

In this study, we mapped monocyte and DC distribution and function in blood and in the nasopharynx (the initial site of infection) of patients with ongoing IAV, IBV, RSV, or SARS-CoV-2 infections and in HCs. Several studies have examined immune responses during severe influenza, in particular, focusing on patients sampled during or immediately following the 2009 H1N1 pandemic (Cole et al., 2017; Oshansky et al., 2014; Dunning et al., 2018; Marion et al., 2016), or patients hospitalized with severe respiratory symptoms (Cole et al., 2017; Gill et al., 2008; Gill et al., 2005; Dunning et al., 2018; Marion et al., 2016); and more recently, the immune dysregulation during severe COVID-19 (Zingaropoli et al., 2021; Del Valle et al., 2020; Merad and Martin, 2020; Mudd et al., 2020). Here, we elucidated the innate myeloid cell composition and responses in a cohort with relatively mild symptoms, advanced age, and underlying comorbidities, typical of seasonal influenza. Finally, we showed that our methods can be adapted to study immune responses in other viral infections, including the current COVID-19 pandemic.

Flow cytometric characterization revealed an influx of monocytes and DCs to the nasopharynx during infection, in line with previous reports in more severe IAV patients (Oshansky et al., 2014; Gill et al., 2008; Gill et al., 2005; Herold et al., 2006). Interestingly, age appeared to differentially skew the CD14+CD16+ IM response in IAV patients. Despite having higher baseline frequencies of circulating CD16-expressing monocytes (The Milieu Intérieur Consortium et al., 2018), older patients have fewer CD14+CD16+ IMs in blood during acute IAV infection and concurrently more IMs in the nasopharynx. The increase in IMs suggests a more inflammatory milieu at the site of infection in older patients, perhaps contributing to disease severity as previously suggested in pandemic influenza (Cole et al., 2017; Oshansky et al., 2014; Kuiken and Taubenberger, 2008; Kuiken et al., 2010). Despite the general increase in CD14+CD16+ IM frequencies, CD14+CD16– CMs remained the most frequent monocyte/DC subset in either compartment implying a functional role for CMs during IAV infection. Similar to studies in paediatric patients (Gill et al., 2008; Gill et al., 2005), we also found that over the course of the illness, DCs appeared to migrate from blood to infiltrate the nasopharynx. However, older patients displayed a weaker recruitment of CD1c+ MDCs. In vitro studies have shown that monocytes can differentiate into type I IFN producing mo-DCs in response to IAV exposure (Cao et al., 2012). It is therefore possible that CMs recruited to the nasopharynx in older individuals preferentially differentiate into IMs rather than mo-DCs. Moreover, cDC2 function is critical for clearance of IAV infection (GeurtsvanKessel et al., 2008). Therefore, diminished recruitment of cDC2s and/or reduced in situ DC differentiation (and therefore delayed or attenuated CD8+ T cell responses) may also contribute more severe disease in older patients.

At the time this study was conceived, DC3s were not yet identified. Guided by a canonical approach and limited by nasopharyngeal cell recovery, we were unable to capture the true heterogeneity of monocyte and DC subsets within the human airways in this study. From later reports establishing DC3 as a distinct DC subset arising from a specific progenitor (Bourdely et al., 2020; Cytlak et al., 2020; Dutertre et al., 2019), especially those describing dysregulated immune responses during SARS-CoV-2 infection (Winheim et al., 2021; Kvedaraite et al., 2021; Affandi et al., 2021), it appears that DC3 may be depleted during severe infection. As the pattern of overall DC depletion from circulation is shared between IAV and SARS-CoV-2 infections, it is plausible that DC3 may be present in the nasopharynx during acute IAV infection. As our comprehension of monocyte and DC heterogeneity expands, it is vital that studies like the present are carried out to accurately map the fate of newly discovered subsets in the airways.

During acute disease, monocytes present in/recruited to the nasopharynx likely contribute to sustained DC recruitment by secreting TNFα, CCL2, CCL3, and CCL7 locally (Oshansky et al., 2014; Gill et al., 2008; Marion et al., 2016). Due to the limited availability of cells in the NPA samples, demonstrating cytokine secretion from nasopharyngeal cells was not possible. However, we noted that in the nasopharynx, CMs, cDC2s, and cDC2s all appeared to mature by upregulating HLA-DR and/or CD86 expression as compared to cells in HCs, suggesting local activation, likely in response to the inflammatory milieu and/or virus exposure. CD86, a critical costimulatory molecule and ligand for CD28 and CTLA-4, is upregulated on monocytes and DCs upon virus infection in vitro and in vivo (Hubo et al., 2013). Lower expression of CD86 on circulating myeloid cells as compared to nasopharyngeal cells during IAV infection suggests migration of mature cells to the nasopharynx, and/or in situ differentiation of monocytes to induced DCs (that may not upregulate maturation markers) in blood during acute IAV infection as previously speculated (Cao et al., 2012). A non-human primate model of chronic simian immunodeficiency virus infection revealed sustained mobilization of MDCs from the bone marrow via blood to the intestinal mucosa, where MDCs remained activated and eventually underwent apoptosis (Wijewardana et al., 2013). In IAV infection, monocytes and DCs are likely recruited to the nasopharynx for a shorter period of time, where they face a similar fate. Some DCs likely traffic antigens to the lymph node to support adaptive responses (Cella et al., 1999; GeurtsvanKessel et al., 2008).

Nasopharyngeal CMs were also more mature in patients with higher viral RNA loads and their recruitment and/or differentiation may be aided by local cytokine production (TNFα and IL-6). Key innate inflammatory cytokines, including TNFα, IL-6, IFNα, IL-10, IL-15, and IL-18, were all significantly elevated early during infection (days 1–5) compared to HCs. TNFα levels strongly correlated with the presence of CMs in both blood and nasopharynx; despite the significant expansion of IMs in blood, supporting previous studies (Cole et al., 2017; Boyette et al., 2017; Dunning et al., 2018; Sprenger et al., 1996). We also demonstrated that the circulating CMs were the most frequent cellular source of TNFα among blood monocytes and DCs, while the TNFα at the site of infection may come from both CMs and the IMs (both subsets found in increased frequencies). Ex vivo, at steady state, human blood CMs and IMs have comparable TNFα secretion irrespective of the nature of stimulation (Boyette et al., 2017). IAV infection, therefore, may skew monocyte subset function, in addition to monocyte distribution and maturation. The broad range of TNFα, IL-6, and IFNα responses seen among the IAV patients suggest that seasonal IAV strains are associated with milder cytokine responses than those observed during infections with 2009 H1N1 pandemic influenza or highly pathogenic avian H5N1 strains (Oshansky et al., 2014; Sakabe et al., 2011; Dunning et al., 2018; Gerlach et al., 2013). Within the setting of seasonal influenza however, older patients had more IMs in the NPA and displayed stronger TNFα responses, locally and systemically.

During IAV infection, the significant expansion of CD14+CD16+ IMs in blood and the nasopharynx could be mediated by the presence of CCL2, a chemokine critical for monocyte chemotaxis (Dean et al., 2008). Upon CCL2 ligation, CCR2 facilitates CM and IM adhesion and transmigration from blood to tissues (Tsou et al., 2007). Therefore, in IAV patients, CCL2 may contribute to recruitment of monocytes and DCs from circulation to the nasopharynx to aid inflammation (Oshansky et al., 2014; Sprenger et al., 1996). Furthermore, elevated IFNα in circulation correlated with reduced viral RNA load, although we saw no evidence of this locally at the site of infection, suggesting that perhaps lower systemic IFN responses can indicate impaired control of viral replication in the nasopharynx, as previously reported (Dunning et al., 2018). This finding also supports previous studies showing that attenuated RIG-I signalling impairs IFN responses in the elderly (Molony et al., 2017) and very young (Marr et al., 2014), both groups at high risk of influenza-associated mortality.

During convalescence, monocyte and DC frequencies, and cytokine levels normalized in blood and the nasopharynx to levels seen in healthy individuals. The local and systemic inflammation observed, therefore, appears limited to the acute phase of disease and wanes during convalescence. Unlike patients infected with the pandemic 2009 H1N1 IAV strain during the pandemic years (2009–2010), where long-lasting immune perturbations were documented Lichtner et al., 2011; the repercussions of relatively mild seasonal IAV infections appear short-lived. This is also in contrast to in vivo studies which demonstrated prolonged DC activation and disruption of DC subset reconstitution in the lungs following IAV infection in mice (Strickland et al., 2014).

In April-May 2020, during the COVID-19 pandemic, the approach and methods described here allowed us to implement this study plan in a rapidly evolving pandemic. Although the patient cohorts were not identical, this endeavour proved the feasibility of using nasopharyngeal aspiration to assess local immune responses during respiratory viral infections. We observed that patients with IBV, RSV, or SARS-CoV-2 also displayed an influx of cells to the nasopharynx during infection. Despite annual reoccurrence of IBV and RSV infections, detailed investigations of the innate cells at the site of infection in patients are quite rare (Gill et al., 2008; Gill et al., 2005), and the technique we describe allows for minimally invasive longitudinal measurement of cellular and molecular aspects of infection. Patients with mild SARS-CoV-2 infection have not been studied as extensively as patients with severe or fatal COVID-19. The cell influx to the nasopharynx in COVID-19 patients did not appear to be due to monocytes but rather due to cDC2s and PDCs, which were reduced in blood, in line with previous reports (Zingaropoli et al., 2021; Peruzzi et al., 2020). Also in line with previous studies (Del Valle et al., 2020; Merad and Martin, 2020; Mudd et al., 2020), we found elevated levels of IL-6 in plasma, and also of TNFα. As different SARS-CoV-2 variants emerge, with concurrently increasing global vaccination rates, incomplete neutralization and/or protection and herd immunity may result in recurring mild SARS-CoV-2 infections. Understanding site-of-infection responses to mild SARS-CoV-2 infections is therefore increasingly relevant, and can be accomplished by the methods we describe in our study.

Finally, to further highlight the importance of studies like ours, we employed a high sensitivity, high-throughput proteomics platform to quantify differences in the nasopharyngeal proteome as compared to blood, in both IAV and SARS-CoV-2 infections. Additionally, this approach allows identification of proteins that cannot be identified by conventional assays that may be limited in breadth of proteome coverage or by limits of detection. We found differentially expressed proteins unique to blood or nasopharynx, and also to IAV or SARS-CoV-2. Preliminary pathway analysis reveals sizeable changes within the nasopharyngeal proteome during infection, especially during SARS-CoV-2 infection. In IAV patients, in line with previous reports (Marion et al., 2016) several innate immune pathway proteins were differentially enriched in the nasopharyngeal proteome, including TNF and IL-6, as seen from ELISA data.

The present study augments our current understanding of the role of monocyte and DC subsets during human respiratory viral infections by highlighting unique dynamics and location-specific functions for each subset over the course of infection. Acute human IAV infection is characterized by an expansion of IMs and monocyte-mediated cytokinemia driving monocyte and DC migration from blood to the nasopharynx, the initial site of IAV infection. Older patients with comorbidities display a recruitment pattern skewed towards IMs and increased TNF rather than CD1c+ MDCs which may contribute to more severe disease and longer duration of hospitalization observed in these patients. IBV, RSV, and mild SARS-CoV-2 infections elicit different patterns on immune cell recruitment to the nasopharynx as compared to IAV infections. We also illustrate the value of comparative high-resolution studies of immune cells in blood and at the site of infection, in order to fully understand their individual contributions to disease and how they orchestrate inflammation synergistically. Similar studies, carried out longitudinally across tissues, will aid resolution of these findings, and allow multivariate modeling of biomarkers of disease severity. Therapeutic approaches which allow selective modulation of monocyte and DC redistribution, maturation, and cytokine/chemokine function may hold the key to reducing influenza-associated disease burden and mortality in the future.

Source Data files have been provided for figures 1-7 and Appendix 2_Table 2 as separate excel files.

1. 1. Affandi AJ
   2. Olesek K
   3. Grabowska J
   4. Nijen Twilhaar MK
   5. Rodríguez E
   6. Saris A
   7. Zwart ES
   8. Nossent EJ
   9. Kalay H
   10. de Kok M
   11. Kazemier G
   12. Stöckl J
   13. van den Eertwegh AJM
   14. de Gruijl TD
   15. Garcia-Vallejo JJ
   16. Storm G
   17. van Kooyk Y
   18. den Haan JMM

   (2021) Cd169 defines activated CD14+ monocytes with enhanced CD8+ T cell activation capacity

   Frontiers in Immunology 12:697840.

   https://doi.org/10.3389/fimmu.2021.697840

   • Google Scholar
2. 1. Alcántara-Hernández M
   2. Leylek R
   3. Wagar LE
   4. Engleman EG
   5. Keler T
   6. Marinkovich MP
   7. Davis MM
   8. Nolan GP
   9. Idoyaga J

   (2017) High-Dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization

   Immunity 47:1037–1050.

   https://doi.org/10.1016/j.immuni.2017.11.001

   • PubMed
   • Google Scholar
3. 1. Baharom F
   2. Thomas S
   3. Bieder A
   4. Hellmér M
   5. Volz J
   6. Sandgren KJ
   7. McInerney GM
   8. Karlsson Hedestam GB
   9. Mellman I
   10. Smed-Sörensen A

   (2015) Protection of human myeloid dendritic cell subsets against influenza A virus infection is differentially regulated upon TLR stimulation

   Journal of Immunology 194:4422–4430.

   https://doi.org/10.4049/jimmunol.1402671

   • PubMed
   • Google Scholar
4. 1. Baharom F
   2. Thomas S
   3. Rankin G
   4. Lepzien R
   5. Pourazar J
   6. Behndig AF
   7. Ahlm C
   8. Blomberg A
   9. Smed-Sörensen A

   (2016) Dendritic cells and monocytes with distinct inflammatory responses reside in lung mucosa of healthy humans

   Journal of Immunology 196:4498–4509.

   https://doi.org/10.4049/jimmunol.1600071

   • PubMed
   • Google Scholar
5. 1. Bourdely P
   2. Anselmi G
   3. Vaivode K
   4. Ramos RN
   5. Missolo-Koussou Y
   6. Hidalgo S
   7. Tosselo J
   8. Nuñez N
   9. Richer W
   10. Vincent-Salomon A
   11. Saxena A
   12. Wood K
   13. Lladser A
   14. Piaggio E
   15. Helft J
   16. Guermonprez P

   (2020) Transcriptional and functional analysis of cd1c+ human dendritic cells identifies a CD163+ subset priming CD8+CD103+ T cells

   Immunity 53:335–352.

   https://doi.org/10.1016/j.immuni.2020.06.002

   • Google Scholar
6. 1. Boyette LB
   2. Macedo C
   3. Hadi K
   4. Elinoff BD
   5. Walters JT
   6. Ramaswami B
   7. Chalasani G
   8. Taboas JM
   9. Lakkis FG
   10. Metes DM

   (2017) Phenotype, function, and differentiation potential of human monocyte subsets

   PLOS ONE 12:e0176460.

   https://doi.org/10.1371/journal.pone.0176460

   • PubMed
   • Google Scholar
7. Preprint

   1. Cagigi A
   2. Yu M
   3. Österberg B
   4. Svensson J
   5. Falck-Jones S
   6. Vangeti S
   7. Åhlberg E
   8. Azizmohammadi L
   9. Warnqvist A
   10. Falck-Jones R
   11. Gubisch PC
   12. Ödemis M
   13. Ghafoor F
   14. Eisele M
   15. Lenart K
   16. Bell M
   17. Johansson N
   18. Albert J
   19. Sälde J
   20. Pettie D
   21. Murphy M
   22. Carter L
   23. King NP
   24. Ols S
   25. Normark J
   26. Ahlm C
   27. Forsell M
   28. Färnert A
   29. Loré K
   30. Smed-Sörensen A

   (2021) Airway Antibodies Emerge According to COVID-19 Severity and Wane Rapidly but Reappear after SARS-CoV-2 Vaccination

   medRxiv.

   https://doi.org/10.1101/2020.11.25.20238592

   • Google Scholar
8. 1. Cao W
   2. Taylor AK
   3. Biber RE
   4. Davis WG
   5. Kim JH
   6. Reber AJ
   7. Chirkova T
   8. De La Cruz JA
   9. Pandey A
   10. Ranjan P
   11. Katz JM
   12. Gangappa S
   13. Sambhara S

   (2012) Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection

   The Journal of Immunology 189:2257–2265.

   https://doi.org/10.4049/jimmunol.1200168

   • PubMed
   • Google Scholar
9. 1. Cella M
   2. Jarrossay D
   3. Facchetti F
   4. Alebardi O
   5. Nakajima H
   6. Lanzavecchia A
   7. Colonna M

   (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

   Nature Medicine 5:919–923.

   https://doi.org/10.1038/11360

   • PubMed
   • Google Scholar
10. 1. Charlson ME
    2. Pompei P
    3. Ales KL
    4. MacKenzie CR

    (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

    Journal of Chronic Diseases 40:373–383.

    https://doi.org/10.1016/0021-9681(87)90171-8

    • PubMed
    • Google Scholar
11. 1. Cole SL
    2. Dunning J
    3. Kok WL
    4. Benam KH
    5. Benlahrech A
    6. Repapi E
    7. Martinez FO
    8. Drumright L
    9. Powell TJ
    10. Bennett M
    11. Elderfield R
    12. Thomas C
    13. MOSAIC investigators
    14. Dong T
    15. McCauley J
    16. Liew FY
    17. Taylor S
    18. Zambon M
    19. Barclay W
    20. Cerundolo V
    21. Openshaw PJ
    22. McMichael AJ
    23. Ho L-P

    (2017) M1-Like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza

    JCI Insight 2:e91868.

    https://doi.org/10.1172/jci.insight.91868

    • PubMed
    • Google Scholar
12. 1. Cytlak U
    2. Resteu A
    3. Pagan S
    4. Green K
    5. Milne P
    6. Maisuria S
    7. McDonald D
    8. Hulme G
    9. Filby A
    10. Carpenter B
    11. Queen R
    12. Hambleton S
    13. Hague R
    14. Lango Allen H
    15. Thaventhiran JED
    16. Doody G
    17. Collin M
    18. Bigley V

    (2020) Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans

    Immunity 53:353–370.

    https://doi.org/10.1016/j.immuni.2020.07.003

    • PubMed
    • Google Scholar
13. 1. Dean RA
    2. Cox JH
    3. Bellac CL
    4. Doucet A
    5. Starr AE
    6. Overall CM

    (2008) Macrophage-Specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx

    Blood 112:3455–3464.

    https://doi.org/10.1182/blood-2007-12-129080

    • PubMed
    • Google Scholar
14. 1. Del Valle DM
    2. Kim-Schulze S
    3. Huang H-H
    4. Beckmann ND
    5. Nirenberg S
    6. Wang B
    7. Lavin Y
    8. Swartz TH
    9. Madduri D
    10. Stock A
    11. Marron TU
    12. Xie H
    13. Patel M
    14. Tuballes K
    15. Van Oekelen O
    16. Rahman A
    17. Kovatch P
    18. Aberg JA
    19. Schadt E
    20. Jagannath S
    21. Mazumdar M
    22. Charney AW
    23. Firpo-Betancourt A
    24. Mendu DR
    25. Jhang J
    26. Reich D
    27. Sigel K
    28. Cordon-Cardo C
    29. Feldmann M
    30. Parekh S
    31. Merad M
    32. Gnjatic S

    (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival

    Nature Medicine 26:1636–1643.

    https://doi.org/10.1038/s41591-020-1051-9

    • PubMed
    • Google Scholar
15. 1. Diao H
    2. Cui G
    3. Wei Y
    4. Chen J
    5. Zuo J
    6. Cao H
    7. Chen Y
    8. Yao H
    9. Tian Z
    10. Li L

    (2014) Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells

    PLOS ONE 9:e92823.

    https://doi.org/10.1371/journal.pone.0092823

    • PubMed
    • Google Scholar
16. 1. Dunning J
    2. Blankley S
    3. Hoang LT
    4. Cox M
    5. Graham CM
    6. James PL
    7. Bloom CI
    8. Chaussabel D
    9. Banchereau J
    10. Brett SJ
    11. Moffatt MF
    12. O’Garra A
    13. Openshaw PJM
    14. MOSAIC Investigators

    (2018) Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza

    Nature Immunology 19:625–635.

    https://doi.org/10.1038/s41590-018-0111-5

    • PubMed
    • Google Scholar
17. 1. Dutertre C-A
    2. Becht E
    3. Irac SE
    4. Khalilnezhad A
    5. Narang V
    6. Khalilnezhad S
    7. Ng PY
    8. van den Hoogen LL
    9. Leong JY
    10. Lee B
    11. Chevrier M
    12. Zhang XM
    13. Yong PJA
    14. Koh G
    15. Lum J
    16. Howland SW
    17. Mok E
    18. Chen J
    19. Larbi A
    20. Tan HKK
    21. Lim TKH
    22. Karagianni P
    23. Tzioufas AG
    24. Malleret B
    25. Brody J
    26. Albani S
    27. van Roon J
    28. Radstake T
    29. Newell EW
    30. Ginhoux F

    (2019) Single-Cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells

    Immunity 51:573–589.

    https://doi.org/10.1016/j.immuni.2019.08.008

    • PubMed
    • Google Scholar
18. 1. Falck-Jones S
    2. Vangeti S
    3. Yu M
    4. Falck-Jones R
    5. Cagigi A
    6. Badolati I
    7. Österberg B
    8. Lautenbach MJ
    9. Åhlberg E
    10. Lin A
    11. Lepzien R
    12. Szurgot I
    13. Lenart K
    14. Hellgren F
    15. Maecker H
    16. Sälde J
    17. Albert J
    18. Johansson N
    19. Bell M
    20. Loré K
    21. Färnert A
    22. Smed-Sörensen A

    (2021) Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

    The Journal of Clinical Investigation 131:e144734.

    https://doi.org/10.1172/JCI144734

    • PubMed
    • Google Scholar
19. 1. Fingerle G
    2. Pforte A
    3. Passlick B
    4. Blumenstein M
    5. Ströbel M
    6. Ziegler-Heitbrock HW

    (1993)

    The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients

    Blood 82:3170–3176.

    • PubMed
    • Google Scholar
20. 1. Gerlach RL
    2. Camp JV
    3. Chu YK
    4. Jonsson CB

    (2013) Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells

    PLOS ONE 8:e78912.

    https://doi.org/10.1371/journal.pone.0078912

    • PubMed
    • Google Scholar
21. 1. GeurtsvanKessel CH
    2. Willart MAM
    3. van Rijt LS
    4. Muskens F
    5. Kool M
    6. Baas C
    7. Thielemans K
    8. Bennett C
    9. Clausen BE
    10. Hoogsteden HC
    11. Osterhaus ADME
    12. Rimmelzwaan GF
    13. Lambrecht BN

    (2008) Clearance of influenza virus from the lung depends on migratory langerin+cd11b- but not plasmacytoid dendritic cells

    The Journal of Experimental Medicine 205:1621–1634.

    https://doi.org/10.1084/jem.20071365

    • PubMed
    • Google Scholar
22. 1. Gill MA
    2. Palucka AK
    3. Barton T
    4. Ghaffar F
    5. Jafri H
    6. Banchereau J
    7. Ramilo O

    (2005) Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

    The Journal of Infectious Diseases 191:1105–1115.

    https://doi.org/10.1086/428589

    • PubMed
    • Google Scholar
23. 1. Gill MA
    2. Long K
    3. Kwon T
    4. Muniz L
    5. Mejias A
    6. Connolly J
    7. Roy L
    8. Banchereau J
    9. Ramilo O

    (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection

    The Journal of Infectious Diseases 198:1667–1676.

    https://doi.org/10.1086/593018

    • PubMed
    • Google Scholar
24. 1. Grissom CK
    2. Brown SM
    3. Kuttler KG
    4. Boltax JP
    5. Jones J
    6. Jephson AR
    7. Orme JF Jr

    (2010) A modified sequential organ failure assessment score for critical care triage

    Disaster Medicine and Public Health Preparedness 4:277–284.

    https://doi.org/10.1001/dmp.2010.40

    • PubMed
    • Google Scholar
25. 1. Hémont C
    2. Neel A
    3. Heslan M
    4. Braudeau C
    5. Josien R

    (2013) Human blood MDC subsets exhibit distinct TLR repertoire and responsiveness

    Journal of Leukocyte Biology 93:599–609.

    https://doi.org/10.1189/jlb.0912452

    • PubMed
    • Google Scholar
26. 1. Herold S
    2. Wulffen W
    3. Steinmueller M
    4. Pleschka S
    5. Kuziel WA
    6. Mack M

    (2006) Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules

    J Immunol 177:1817–1824.

    https://doi.org/10.4049/jimmunol.177.3.1817

    • Google Scholar
27. 1. Hubo M
    2. Trinschek B
    3. Kryczanowsky F
    4. Tuettenberg A
    5. Steinbrink K
    6. Jonuleit H

    (2013) Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells

    Frontiers in Immunology 4:82.

    https://doi.org/10.3389/fimmu.2013.00082

    • PubMed
    • Google Scholar
28. Website

    1. Intensivvårdsregistret S

    (2018) SIR:s riktlinje för registrering av SOFA

    Accessed August 1, 2021.

    https://www.icuregswe.org/globalassets/riktlinjer/sofa.pdf
29. 1. Jakubzick C
    2. Gautier EL
    3. Gibbings SL
    4. Sojka DK
    5. Schlitzer A
    6. Johnson TE
    7. Ivanov S
    8. Duan Q
    9. Bala S
    10. Condon T
    11. van Rooijen N
    12. Grainger JR
    13. Belkaid Y
    14. Ma’ayan A
    15. Riches DWH
    16. Yokoyama WM
    17. Ginhoux F
    18. Henson PM
    19. Randolph GJ

    (2013) Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes

    Immunity 39:599–610.

    https://doi.org/10.1016/j.immuni.2013.08.007

    • PubMed
    • Google Scholar
30. 1. Jochems SP
    2. Marcon F
    3. Carniel BF
    4. Holloway M
    5. Mitsi E
    6. Smith E
    7. Gritzfeld JF
    8. Solórzano C
    9. Reiné J
    10. Pojar S
    11. Nikolaou E
    12. German EL
    13. Hyder-Wright A
    14. Hill H
    15. Hales C
    16. de Steenhuijsen Piters WAA
    17. Bogaert D
    18. Adler H
    19. Zaidi S
    20. Connor V
    21. Gordon SB
    22. Rylance J
    23. Nakaya HI
    24. Ferreira DM

    (2018) Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

    Nature Immunology 19:1299–1308.

    https://doi.org/10.1038/s41590-018-0231-y

    • PubMed
    • Google Scholar
31. 1. Jongbloed SL
    2. Kassianos AJ
    3. McDonald KJ
    4. Clark GJ
    5. Ju X
    6. Angel CE
    7. Chen C-JJ
    8. Dunbar PR
    9. Wadley RB
    10. Jeet V
    11. Vulink AJE
    12. Hart DNJ
    13. Radford KJ

    (2010) Human CD141+ (BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

    The Journal of Experimental Medicine 207:1247–1260.

    https://doi.org/10.1084/jem.20092140

    • PubMed
    • Google Scholar
32. 1. Kolberg L
    2. Raudvere U
    3. Kuzmin I
    4. Vilo J
    5. Peterson H

    (2020) Gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset G: profiler

    F1000Research 9:ELIXIR-709.

    https://doi.org/10.12688/f1000research.24956.2

    • PubMed
    • Google Scholar
33. 1. Kuiken T
    2. Taubenberger JK

    (2008) Pathology of human influenza revisited

    Vaccine 26 Suppl 4:D59–D66.

    https://doi.org/10.1016/j.vaccine.2008.07.025

    • PubMed
    • Google Scholar
34. 1. Kuiken T
    2. van den Brand J
    3. van Riel D
    4. Pantin-Jackwood M
    5. Swayne DE

    (2010) Comparative pathology of select agent influenza A virus infections

    Veterinary Pathology 47:893–914.

    https://doi.org/10.1177/0300985810378651

    • PubMed
    • Google Scholar
35. 1. Kvedaraite E
    2. Hertwig L
    3. Sinha I
    4. Ponzetta A
    5. Hed Myrberg I
    6. Lourda M
    7. Dzidic M
    8. Akber M
    9. Klingström J
    10. Folkesson E
    11. Muvva JR
    12. Chen P
    13. Gredmark-Russ S
    14. Brighenti S
    15. Norrby-Teglund A
    16. Eriksson LI
    17. Rooyackers O
    18. Aleman S
    19. Strålin K
    20. Ljunggren HG
    21. Ginhoux F
    22. Björkström NK
    23. Henter JI
    24. Svensson M
    25. Karolinska KI/K COVID-19 Study Group

    (2021) Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

    PNAS 118:e2018587118.

    https://doi.org/10.1073/pnas.2018587118

    • PubMed
    • Google Scholar
36. 1. Kwissa M
    2. Nakaya HI
    3. Onlamoon N
    4. Wrammert J
    5. Villinger F
    6. Perng GC
    7. Yoksan S
    8. Pattanapanyasat K
    9. Chokephaibulkit K
    10. Ahmed R
    11. Pulendran B

    (2014) Dengue virus infection induces expansion of a CD14 (+) CD16 (+) monocyte population that stimulates plasmablast differentiation

    Cell Host & Microbe 16:115–127.

    https://doi.org/10.1016/j.chom.2014.06.001

    • PubMed
    • Google Scholar
37. 1. Liberzon A
    2. Subramanian A
    3. Pinchback R
    4. Thorvaldsdóttir H
    5. Tamayo P
    6. Mesirov JP

    (2011) Molecular signatures database (msigdb) 3.0

    Bioinformatics 27:1739–1740.

    https://doi.org/10.1093/bioinformatics/btr260

    • PubMed
    • Google Scholar
38. 1. Lichtner M
    2. Mastroianni CM
    3. Rossi R
    4. Russo G
    5. Belvisi V
    6. Marocco R
    7. Mascia C
    8. Del Borgo C
    9. Mengoni F
    10. Sauzullo I
    11. d’Ettorre G
    12. D’Agostino C
    13. Massetti AP
    14. Vullo V

    (2011) Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection

    PLOS ONE 6:e19872.

    https://doi.org/10.1371/journal.pone.0019872

    • PubMed
    • Google Scholar
39. 1. Marion T
    2. Elbahesh H
    3. Thomas PG
    4. DeVincenzo JP
    5. Webby R
    6. Schughart K

    (2016) Respiratory mucosal proteome quantification in human influenza infections

    PLOS ONE 11:e0153674.

    https://doi.org/10.1371/journal.pone.0153674

    • PubMed
    • Google Scholar
40. 1. Marr N
    2. Wang TI
    3. Kam SHY
    4. Hu YS
    5. Sharma AA
    6. Lam A
    7. Markowski J
    8. Solimano A
    9. Lavoie PM
    10. Turvey SE

    (2014) Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children

    Journal of Immunology 192:948–957.

    https://doi.org/10.4049/jimmunol.1302007

    • PubMed
    • Google Scholar
41. 1. McGill J
    2. Van Rooijen N
    3. Legge KL

    (2008) Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs

    The Journal of Experimental Medicine 205:1635–1646.

    https://doi.org/10.1084/jem.20080314

    • PubMed
    • Google Scholar
42. 1. Merad M
    2. Martin JC

    (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

    Nature Reviews Immunology 20:355–362.

    https://doi.org/10.1038/s41577-020-0331-4

    • PubMed
    • Google Scholar
43. 1. Merico D
    2. Isserlin R
    3. Stueker O
    4. Emili A
    5. Bader GD

    (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation

    PLOS ONE 5:e13984.

    https://doi.org/10.1371/journal.pone.0013984

    • PubMed
    • Google Scholar
44. 1. Mick E
    2. Kamm J
    3. Pisco AO
    4. Ratnasiri K
    5. Babik JM
    6. Castañeda G
    7. DeRisi JL
    8. Detweiler AM
    9. Hao SL
    10. Kangelaris KN
    11. Kumar GR
    12. Li LM
    13. Mann SA
    14. Neff N
    15. Prasad PA
    16. Serpa PH
    17. Shah SJ
    18. Spottiswoode N
    19. Tan M
    20. Calfee CS
    21. Christenson SA
    22. Kistler A
    23. Langelier C

    (2020) Upper airway gene expression reveals suppressed immune responses to SARS-cov-2 compared with other respiratory viruses

    Nature Communications 11:5854.

    https://doi.org/10.1038/s41467-020-19587-y

    • PubMed
    • Google Scholar
45. 1. Molony RD
    2. Nguyen JT
    3. Kong Y
    4. Montgomery RR
    5. Shaw AC
    6. Iwasaki A

    (2017) Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes

    Science Signaling 10:eaan2392.

    https://doi.org/10.1126/scisignal.aan2392

    • PubMed
    • Google Scholar
46. 1. Mount AM
    2. Belz GT

    (2010) Mouse models of viral infection: influenza infection in the lung

    Methods in Molecular Biology 595:299–318.

    https://doi.org/10.1007/978-1-60761-421-0_20

    • PubMed
    • Google Scholar
47. 1. Mudd PA
    2. Crawford JC
    3. Turner JS
    4. Souquette A
    5. Reynolds D
    6. Bender D
    7. Bosanquet JP
    8. Anand NJ
    9. Striker DA
    10. Martin RS
    11. Boon ACM
    12. House SL
    13. Remy KE
    14. Hotchkiss RS
    15. Presti RM
    16. O’Halloran JA
    17. Powderly WG
    18. Thomas PG
    19. Ellebedy AH

    (2020) Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm

    Science Advances 6:50.

    https://doi.org/10.1126/sciadv.abe3024

    • PubMed
    • Google Scholar
48. 1. Oshansky CM
    2. Gartland AJ
    3. Wong S-S
    4. Jeevan T
    5. Wang D
    6. Roddam PL
    7. Caniza MA
    8. Hertz T
    9. Devincenzo JP
    10. Webby RJ
    11. Thomas PG

    (2014) Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load

    American Journal of Respiratory and Critical Care Medicine 189:449–462.

    https://doi.org/10.1164/rccm.201309-1616OC

    • PubMed
    • Google Scholar
49. 1. Patel AA
    2. Zhang Y
    3. Fullerton JN
    4. Boelen L
    5. Rongvaux A
    6. Maini AA
    7. Bigley V
    8. Flavell RA
    9. Gilroy DW
    10. Asquith B
    11. Macallan D
    12. Yona S

    (2017) The fate and lifespan of human monocyte subsets in steady state and systemic inflammation

    The Journal of Experimental Medicine 214:1913–1923.

    https://doi.org/10.1084/jem.20170355

    • PubMed
    • Google Scholar
50. 1. Peruzzi B
    2. Bencini S
    3. Capone M
    4. Mazzoni A
    5. Maggi L
    6. Salvati L
    7. Vanni A
    8. Orazzini C
    9. Nozzoli C
    10. Morettini A
    11. Poggesi L
    12. Pieralli F
    13. Peris A
    14. Bartoloni A
    15. Vannucchi AM
    16. Liotta F
    17. Caporale R
    18. Cosmi L
    19. Annunziato F

    (2020) Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid dC in SARS-cov-2 infection

    Immunology 161:345–353.

    https://doi.org/10.1111/imm.13254

    • PubMed
    • Google Scholar
51. 1. Raudvere U
    2. Kolberg L
    3. Kuzmin I
    4. Arak T
    5. Adler P
    6. Peterson H
    7. Vilo J

    (2019) G: profiler: a web server for functional enrichment analysis and conversions of gene Lists (2019 update)

    Nucleic Acids Research 47:W191–W198.

    https://doi.org/10.1093/nar/gkz369

    • PubMed
    • Google Scholar
52. 1. Rohloff JC
    2. Gelinas AD
    3. Jarvis TC
    4. Ochsner UA
    5. Schneider DJ
    6. Gold L
    7. Janjic N

    (2014) Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents

    Molecular Therapy. Nucleic Acids 3:10.

    https://doi.org/10.1038/mtna.2014.49

    • PubMed
    • Google Scholar
53. 1. Sakabe S
    2. Iwatsuki-Horimoto K
    3. Takano R
    4. Nidom CA
    5. Le MTQ
    6. Nagamura-Inoue T
    7. Horimoto T
    8. Yamashita N
    9. Kawaoka Y

    (2011) Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses

    The Journal of General Virology 92:1428–1434.

    https://doi.org/10.1099/vir.0.030346-0

    • PubMed
    • Google Scholar
54. 1. Sanders CJ
    2. Doherty PC
    3. Thomas PG

    (2011) Respiratory epithelial cells in innate immunity to influenza virus infection

    Cell and Tissue Research 343:13–21.

    https://doi.org/10.1007/s00441-010-1043-z

    • PubMed
    • Google Scholar
55. 1. See P
    2. Dutertre C-A
    3. Chen J
    4. Günther P
    5. McGovern N
    6. Irac SE
    7. Gunawan M
    8. Beyer M
    9. Händler K
    10. Duan K
    11. Sumatoh HRB
    12. Ruffin N
    13. Jouve M
    14. Gea-Mallorquí E
    15. Hennekam RCM
    16. Lim T
    17. Yip CC
    18. Wen M
    19. Malleret B
    20. Low I
    21. Shadan NB
    22. Fen CFS
    23. Tay A
    24. Lum J
    25. Zolezzi F
    26. Larbi A
    27. Poidinger M
    28. Chan JKY
    29. Chen Q
    30. Rénia L
    31. Haniffa M
    32. Benaroch P
    33. Schlitzer A
    34. Schultze JL
    35. Newell EW
    36. Ginhoux F

    (2017) Mapping the human DC lineage through the integration of high-dimensional techniques

    Science 356:eaag3009.

    https://doi.org/10.1126/science.aag3009

    • PubMed
    • Google Scholar
56. 1. Segura E
    2. Durand M
    3. Amigorena S

    (2013) Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells

    The Journal of Experimental Medicine 210:1035–1047.

    https://doi.org/10.1084/jem.20121103

    • PubMed
    • Google Scholar
57. 1. Smed-Sörensen A
    2. Chalouni C
    3. Chatterjee B
    4. Cohn L
    5. Blattmann P
    6. Nakamura N
    7. Delamarre L
    8. Mellman I

    (2012) Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells

    PLOS Pathogens 8:e1002572.

    https://doi.org/10.1371/journal.ppat.1002572

    • PubMed
    • Google Scholar
58. 1. Spörri R
    2. Reis e Sousa C

    (2005) Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

    Nature Immunology 6:163–170.

    https://doi.org/10.1038/ni1162

    • PubMed
    • Google Scholar
59. 1. Sprenger H
    2. Meyer RG
    3. Kaufmann A
    4. Bussfeld D
    5. Rischkowsky E
    6. Gemsa D

    (1996) Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection

    The Journal of Experimental Medicine 184:1191–1196.

    https://doi.org/10.1084/jem.184.3.1191

    • PubMed
    • Google Scholar
60. 1. Stramer SL
    2. Collins C
    3. Nugent T
    4. Wang X
    5. Fuschino M
    6. Heitman JW
    7. Law J
    8. Krysztof DE
    9. Kiely N
    10. Todd D
    11. Vermeulen NMJ
    12. Harrington K
    13. Kamel H
    14. Kelvin DJ
    15. Busch MP
    16. St George K
    17. Hewlett IK
    18. Linnen JM
    19. Norris PJ
    20. NHLBI Retrovirus Epidemiology Donor Study-II

    (2012) Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors

    The Journal of Infectious Diseases 205:886–894.

    https://doi.org/10.1093/infdis/jir863

    • PubMed
    • Google Scholar
61. 1. Strickland DH
    2. Fear V
    3. Shenton S
    4. Wikstrom ME
    5. Zosky G
    6. Larcombe AN
    7. Holt PG
    8. Berry C
    9. von Garnier C
    10. Stumbles PA

    (2014) Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection

    PLOS ONE 9:e111520.

    https://doi.org/10.1371/journal.pone.0111520

    • PubMed
    • Google Scholar
62. 1. Svensson MJ
    2. Lind I
    3. Wirgart BZ
    4. Östlund MR
    5. Albert J

    (2014) Performance of the simplexaperformance of the simplexa

    Scandinavian Journal of Infectious Diseases 46:825–831.

    https://doi.org/10.3109/00365548.2014.946444

    • PubMed
    • Google Scholar
63. 1. Tellier R

    (2006) Review of aerosol transmission of influenza A virus

    Emerging Infectious Diseases 12:1657–1662.

    https://doi.org/10.3201/eid1211.060426

    • PubMed
    • Google Scholar
64. 1. The Milieu Intérieur Consortium
    2. Patin E
    3. Hasan M
    4. Bergstedt J
    5. Rouilly V
    6. Libri V
    7. Urrutia A
    8. Alanio C
    9. Scepanovic P
    10. Hammer C
    11. Jönsson F
    12. Beitz B
    13. Quach H
    14. Lim YW
    15. Hunkapiller J
    16. Zepeda M
    17. Green C
    18. Piasecka B
    19. Leloup C
    20. Rogge L
    21. Huetz F
    22. Peguillet I
    23. Lantz O
    24. Fontes M
    25. Di Santo JP
    26. Thomas S
    27. Fellay J
    28. Duffy D
    29. Quintana-Murci L
    30. Albert ML

    (2018) Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors

    Nature Immunology 19:302–314.

    https://doi.org/10.1038/s41590-018-0049-7

    • PubMed
    • Google Scholar
65. 1. Tisoncik JR
    2. Korth MJ
    3. Simmons CP
    4. Farrar J
    5. Martin TR
    6. Katze MG

    (2012) Into the eye of the cytokine storm

    Microbiology and Molecular Biology Reviews 76:16–32.

    https://doi.org/10.1128/MMBR.05015-11

    • PubMed
    • Google Scholar
66. 1. Tsou C-L
    2. Peters W
    3. Si Y
    4. Slaymaker S
    5. Aslanian AM
    6. Weisberg SP
    7. Mack M
    8. Charo IF

    (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites

    The Journal of Clinical Investigation 117:902–909.

    https://doi.org/10.1172/JCI29919

    • PubMed
    • Google Scholar
67. 1. Vangeti S
    2. Gertow J
    3. Yu M
    4. Liu S
    5. Baharom F
    6. Scholz S
    7. Friberg D
    8. Starkhammar M
    9. Ahlberg A
    10. Smed-Sörensen A

    (2019) Human blood and tonsil plasmacytoid dendritic cells display similar gene expression profiles but exhibit differential type I IFN responses to influenza A virus infection

    Journal of Immunology 202:2069–2081.

    https://doi.org/10.4049/jimmunol.1801191

    • PubMed
    • Google Scholar
68. 1. Villani A-C
    2. Satija R
    3. Reynolds G
    4. Sarkizova S
    5. Shekhar K
    6. Fletcher J
    7. Griesbeck M
    8. Butler A
    9. Zheng S
    10. Lazo S
    11. Jardine L
    12. Dixon D
    13. Stephenson E
    14. Nilsson E
    15. Grundberg I
    16. McDonald D
    17. Filby A
    18. Li W
    19. De Jager PL
    20. Rozenblatt-Rosen O
    21. Lane AA
    22. Haniffa M
    23. Regev A
    24. Hacohen N

    (2017) Single-Cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

    Science 356:eaah4573.

    https://doi.org/10.1126/science.aah4573

    • PubMed
    • Google Scholar
69. 1. Vincent J-L
    2. Moreno R
    3. Takala J
    4. Willatts S
    5. De Mendonça A
    6. Bruining H
    7. Reinhart CK
    8. Suter PM
    9. Thijs LG

    (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure

    Intensive Care Medicine 22:707–710.

    https://doi.org/10.1007/BF01709751

    • PubMed
    • Google Scholar
70. 1. Wang J
    2. Nikrad MP
    3. Travanty EA
    4. Zhou B
    5. Phang T
    6. Gao B
    7. Alford T
    8. Ito Y
    9. Nahreini P
    10. Hartshorn K
    11. Wentworth D
    12. Dinarello CA
    13. Mason RJ

    (2012) Innate immune response of human alveolar macrophages during influenza A infection

    PLOS ONE 7:e29879.

    https://doi.org/10.1371/journal.pone.0029879

    • PubMed
    • Google Scholar
71. Website

    1. WHO

    (2018) Factsheet: Influenza (Seasonal)

    Accessed October 21, 2019.

    https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)?gclid=CjwKCAiA0JKfBhBIEiwAPhZXD1o_HJ4MEApr2wr9ZzPzM9sfaCYF48tgz1wjCrwIu7_mirvTkqNd2RoCK5QQAvD_BwE
72. 1. Wijewardana V
    2. Kristoff J
    3. Xu C
    4. Ma D
    5. Haret-Richter G
    6. Stock JL
    7. Policicchio BB
    8. Mobley AD
    9. Nusbaum R
    10. Aamer H
    11. Trichel A
    12. Ribeiro RM
    13. Apetrei C
    14. Pandrea I

    (2013) Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections

    PLOS Pathogens 9:e1003600.

    https://doi.org/10.1371/journal.ppat.1003600

    • PubMed
    • Google Scholar
73. 1. Williams SA
    2. Ostroff R
    3. Hinterberg MA
    4. Coresh J
    5. Ballantyne CM
    6. Matsushita K
    7. Mueller CE
    8. Walter J
    9. Jonasson C
    10. Holman RR
    11. Shah SH
    12. Sattar N
    13. Taylor R
    14. Lean ME
    15. Kato S
    16. Shimokawa H
    17. Sakata Y
    18. Nochioka K
    19. Parikh CR
    20. Coca SG
    21. Omland T
    22. Chadwick J
    23. Astling D
    24. Hagar Y
    25. Kureshi N
    26. Loupy K
    27. Paterson C
    28. Primus J
    29. Simpson M
    30. Trujillo NP
    31. Ganz P

    (2022) A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

    Science Translational Medicine 14:eabj9625.

    https://doi.org/10.1126/scitranslmed.abj9625

    • PubMed
    • Google Scholar
74. 1. Winheim E
    2. Rinke L
    3. Lutz K
    4. Reischer A
    5. Leutbecher A
    6. Wolfram L
    7. Rausch L
    8. Kranich J
    9. Wratil PR
    10. Huber JE
    11. Baumjohann D
    12. Rothenfusser S
    13. Schubert B
    14. Hilgendorff A
    15. Hellmuth JC
    16. Scherer C
    17. Muenchhoff M
    18. von Bergwelt-Baildon M
    19. Stark K
    20. Straub T
    21. Brocker T
    22. Keppler OT
    23. Subklewe M
    24. Krug AB
    25. Suthar M

    (2021) Impaired function and delayed regeneration of dendritic cells in COVID-19

    PLOS Pathogens 17:e1009742.

    https://doi.org/10.1371/journal.ppat.1009742

    • Google Scholar
75. 1. Zhou F
    2. Yu T
    3. Du R
    4. Fan G
    5. Liu Y
    6. Liu Z
    7. Xiang J
    8. Wang Y
    9. Song B
    10. Gu X
    11. Guan L
    12. Wei Y
    13. Li H
    14. Wu X
    15. Xu J
    16. Tu S
    17. Zhang Y
    18. Chen H
    19. Cao B

    (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, china: a retrospective cohort study

    Lancet 395:1054–1062.

    https://doi.org/10.1016/S0140-6736(20)30566-3

    • PubMed
    • Google Scholar
76. 1. Zingaropoli MA
    2. Nijhawan P
    3. Carraro A
    4. Pasculli P
    5. Zuccalà P
    6. Perri V
    7. Marocco R
    8. Kertusha B
    9. Siccardi G
    10. Del Borgo C
    11. Curtolo A
    12. Ajassa C
    13. Iannetta M
    14. Ciardi MR
    15. Mastroianni CM
    16. Lichtner M

    (2021) Increased scd163 and scd14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia

    Frontiers in Immunology 12:627548.

    https://doi.org/10.3389/fimmu.2021.627548

    • PubMed
    • Google Scholar

Author details

1. Sindhu Vangeti

   Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-3404-6878

2. Sara Falck-Jones

   Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

3. Meng Yu

   Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

4. Björn Österberg

   Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Data curation, Investigation, Writing – review and editing

   Competing interests

   No competing interests declared

5. Sang Liu

   Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Data curation, Investigation, Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

6. Muhammad Asghar

   1. Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
   2. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Resources, Data curation, Supervision, Validation, Investigation, Writing – review and editing

   Competing interests

   No competing interests declared

7. Klara Sondén

   1. Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
   2. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

   Contribution

   Resources, Data curation, Supervision, Validation, Investigation, Writing – review and editing

   Competing interests

   No competing interests declared

8. Clare Paterson

   SomaLogic Operating Co., Inc,, Boulder, United States

   Contribution

   Data curation, Software, Formal analysis, Writing – review and editing

   Competing interests

   is an employee and stockholder of SomaLogic Inc

9. Penn Whitley

   Boulder Bioconsulting Inc, Boulder, United States

   Contribution

   Data curation, Software, Formal analysis, Writing – review and editing

   Competing interests

   is a consultant for Boulder Bioconsulting, Inc

10. Jan Albert

    1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    2. Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden

    Contribution

    Resources, Data curation, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing – review and editing

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-9020-0521

11. Niclas Johansson

    1. Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    2. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

    Contribution

    Conceptualization, Resources, Data curation, Formal analysis, Supervision, Validation, Investigation, Methodology, Project administration, Writing – review and editing

    Competing interests

    No competing interests declared

12. Anna Färnert

    1. Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    2. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

    Contribution

    Conceptualization, Resources, Data curation, Validation, Investigation, Visualization, Methodology, Project administration, Writing – review and editing

    Competing interests

    No competing interests declared

13. Anna Smed-Sörensen

    Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Contribution

    Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing

    For correspondence

    anna.smed.sorensen@ki.se

    Competing interests

    is a consultant to Astra-Zeneca on studies not related to the present study

    "This ORCID iD identifies the author of this article:" 0000-0001-6966-7039

• 2,000

  views

• 243

  downloads

• 15

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.